SRTA Strata Critical Medical, Inc.
$5.20▲ +1.27%
Healthcare
Other
After hours
$5.15▼ -0.96%
Sep 11, 7:30 PM ET
Volume 770.7K
Avg Volume (10D) 836.8K
Key Metrics & Fundamentals
Market Cap
$459.59M
P/E Ratio
–
Div Yield
–%
52W Range
3.95 - 6.50
% vs 50 MA
-5.38%
% vs 200 MA
1.60%
RSI-14
38.3
MACD Histogram
-0.1000
Beta (1Y vs SPY)
2.11
Free Cash Flow
$2.88M
Gross Rev
$72.51M
Gross Profit
$15.22M
EBITDA
$8.55M
COGS
$57.29M
Operating Exp
$20.62M
Operating Income
-$5.41M
EBIT
-$5.41M
Pretax Income
-$10.52M
Net Income
-$10.52M
EPS (Diluted)
-0.12
Price & Volume History
Loading chart…
Recent News
Joby Aviation Files Resale Prospectus for 2.4 Million Earn-Out Shares Tied to Blade Acquisition
Benzinga · Sep 11, 2026 2:25 PM
Strata Critical to Present at the 2026 Jefferies Healthcare Services and Technology Conference
GlobeNewswire · Sep 8, 2026 9:05 PM
NACD Announces Finalists for 2026 Directorship 100 B. Kenneth West Lifetime Achievement Award and Directors of the Year
PR Newswire · Aug 24, 2026 6:15 PM
Strata Critical Medical, Inc. (SRTA) Upgraded to Buy: What Does It Mean for the Stock?
Zacks · Aug 24, 2026 4:00 PM
Does Strata Critical Medical, Inc. (SRTA) Have the Potential to Rally 47.28% as Wall Street Analysts Expect?
Zacks · Aug 24, 2026 1:55 PM
Strata Critical Medical (SRTA) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 11, 2026 5:35 PM
Immersion Investment Views Strata Critical Medical (SRTA) as a “Babushka Doll”
Insider Monkey · Aug 11, 2026 1:44 PM
Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?
Zacks · Aug 6, 2026 4:20 PM
Strata Critical Medical, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 4, 2026 10:29 PM
Strata Critical Medical Inc (SRTA) (Q2 2026) Earnings Call Highlights: Revenue Surges 60. ...
GuruFocus.com · Aug 4, 2026 7:01 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See SRTA's money flow as a full page
Social Sentiment
No Reddit posts found for SRTA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.